FDA clears metformin for patients with impaired kidney function

America’s Food and Drug Administration (FDA) has given the OK for diabetes drugs that contain metformin to be used by some patients with impaired kidney function.

Currently, the use of metformin is not recommended for patients with reduced kidney function. But, after investigating a number of studies looking at the impact of metformin on kidney function, the FDA has announced that the drug can be used safely by patients with mild kidney impairment.

Some patients with moderate kidney function might also benefit from metformin, the agency announced on its website.

The change to the labelling will affect 18 drugs, with changes needed to reflect the new information profile. Specific recommendations regarding use of the drugs will also be given to people with impaired kidney function.

For more information, and to see which drugs are affected, visit http://www.fda.gov/Drugs/DrugSafety/ucm493244.htm